| P50 | author | Maarten IJzerman | Q38548703 |
| | Michelle Ma Kip | Q88592080 |
| | Hendrik Koffijberg | Q92138499 |
| P2093 | author name string | Ron Kusters | |
| | Lotte Mg Steuten | |
| P2860 | cites work | A Systematic Review and Collaborative Meta-Analysis to Determine the Incremental Value of Copeptin for Rapid Rule-Out of Acute Myocardial Infarction | Q22252541 |
| | Beyond diagnostic accuracy: the clinical utility of diagnostic tests | Q27004609 |
| | Direct hospital costs of chest pain patients attending the emergency department: a retrospective study | Q33242296 |
| | High-sensitive troponin T assay for the diagnosis of acute myocardial infarction: an economic evaluation | Q33786119 |
| | Incremental value of copeptin for rapid rule out of acute myocardial infarction | Q34018239 |
| | Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). | Q34036575 |
| | Evaluation of the emergency department chest pain patient | Q34081555 |
| | Copeptin improves early diagnosis of acute myocardial infarction | Q34113939 |
| | Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man | Q34296037 |
| | Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. | Q34804612 |
| | Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study | Q35059506 |
| | Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction | Q35569452 |
| | Distraction from randomization in diagnostic research | Q36357362 |
| | ??? | Q22242895 |
| | Comparative accuracy: assessing new tests against existing diagnostic pathways | Q36468809 |
| | Grading quality of evidence and strength of recommendations for diagnostic tests and strategies | Q36661809 |
| | The evaluation of diagnostic tests: evidence on technical and diagnostic accuracy, impact on patient outcome and cost-effectiveness is needed. | Q36972221 |
| | The combination of high sensitivity troponin T and copeptin facilitates early rule-out of ACS: a prospective observational study | Q36972479 |
| | Investigation of a multimarker approach to the initial assessment of patients with acute chest pain. | Q37498433 |
| | Methods to elicit beliefs for Bayesian priors: a systematic review | Q37588926 |
| | Diagnostic accuracy of copeptin sensitivity and specificity in patients with suspected non-ST-elevation myocardial infarction with troponin I below the 99th centile at presentation | Q37684756 |
| | Early assessment of medical technologies to inform product development and market access: a review of methods and applications | Q37923478 |
| | Assessing the value of diagnostic tests: a framework for designing and evaluating trials | Q37987071 |
| | Critical review and meta-analysis on the combination of heart-type fatty acid binding protein (H-FABP) and troponin for early diagnosis of acute myocardial infarction | Q38055628 |
| | Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome | Q38075181 |
| | High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis. | Q38539406 |
| | A FABP-ulous 'rule out' strategy? Heart fatty acid binding protein and troponin for rapid exclusion of acute myocardial infarction. | Q39751450 |
| | Health care costs in the last year of life--the Dutch experience | Q40315173 |
| | Longitudinal trends in laboratory test utilization at a large tertiary care university hospital in Sweden | Q42606113 |
| | Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome | Q43160493 |
| | Early diagnosis of myocardial infarction with sensitive cardiac troponin assays | Q43285257 |
| | Probability elicitation to inform early health economic evaluations of new medical technologies: a case study in heart failure disease management. | Q44210023 |
| | Combined copeptin and troponin to rule out myocardial infarction in patients with chest pain and a history of coronary artery disease. | Q44479215 |
| | Methods to elicit experts' beliefs over uncertain quantities: application to a cost effectiveness transition model of negative pressure wound therapy for severe pressure ulceration | Q44698344 |
| | Performance of a sensitive troponin assay in the early diagnosis of acute myocardial infarction in the emergency department | Q46432572 |
| | Analytical and clinical performance of a fully automated cardiac multi-markers strategy based on protein biochip microarray technology | Q46982189 |
| | Early technology assessment of new medical devices | Q47961457 |
| | From biomarkers to medical tests: the changing landscape of test evaluation | Q50147025 |
| | Proteomic approach to the diagnosis of acute coronary syndrome: preliminary results. | Q51592832 |
| | Rapidly rule out acute myocardial infarction by combining copeptin and heart-type fatty acid-binding protein with cardiac troponin. | Q53591620 |
| | Belief elicitation to populate health economic models of medical diagnostic devices in development. | Q53599945 |
| P433 | issue | 1 | |
| P921 | main subject | myocardial infarction | Q12152 |
| P304 | page(s) | 31-41 | |
| P577 | publication date | 2016-10-19 | |
| P1433 | published in | Journal of Evaluation in Clinical Practice | Q15767649 |
| P1476 | title | Using expert elicitation to estimate the potential impact of improved diagnostic performance of laboratory tests: a case study on rapid discharge of suspected non-ST elevation myocardial infarction patients | |
| P478 | volume | 24 | |